Gallant Dm

550 total citations
56 papers, 419 citations indexed

About

Gallant Dm is a scholar working on Psychiatry and Mental health, Philosophy and Pharmacology. According to data from OpenAlex, Gallant Dm has authored 56 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Psychiatry and Mental health, 9 papers in Philosophy and 8 papers in Pharmacology. Recurrent topics in Gallant Dm's work include Schizophrenia research and treatment (18 papers), Mental Health and Psychiatry (9 papers) and Treatment of Major Depression (7 papers). Gallant Dm is often cited by papers focused on Schizophrenia research and treatment (18 papers), Mental Health and Psychiatry (9 papers) and Treatment of Major Depression (7 papers). Gallant Dm collaborates with scholars based in United States. Gallant Dm's co-authors include R Guerrero-Figueroa, Christof Kessler, George Rb, Phillips Jh, Hugh Collins, Roger Downer, Peter V. Rabins and W.N. Shelton and has published in prestigious journals such as PubMed.

In The Last Decade

Gallant Dm

54 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gallant Dm United States 11 248 88 60 56 53 56 419
LEON J. HEKIMIAN United States 8 275 1.1× 74 0.8× 73 1.2× 47 0.8× 64 1.2× 14 403
Simpson Gm United States 14 256 1.0× 69 0.8× 64 1.1× 66 1.2× 85 1.6× 49 476
P. Dick United Kingdom 11 238 1.0× 157 1.8× 39 0.7× 34 0.6× 82 1.5× 25 418
Ayd Fj United States 12 204 0.8× 44 0.5× 59 1.0× 55 1.0× 108 2.0× 50 409
Eugene M. Caffey United States 13 486 2.0× 199 2.3× 39 0.7× 62 1.1× 89 1.7× 24 643
Donald M. Gallant United States 13 203 0.8× 91 1.0× 97 1.6× 38 0.7× 54 1.0× 78 535
Hilde Lunde Norway 10 177 0.7× 79 0.9× 116 1.9× 74 1.3× 58 1.1× 16 486
Lehmann He Canada 10 183 0.7× 42 0.5× 74 1.2× 23 0.4× 100 1.9× 76 364
Andrew Malleson United Kingdom 10 187 0.8× 35 0.4× 86 1.4× 24 0.4× 81 1.5× 15 500
H. M. Emrich Germany 13 215 0.9× 80 0.9× 92 1.5× 93 1.7× 86 1.6× 27 542

Countries citing papers authored by Gallant Dm

Since Specialization
Citations

This map shows the geographic impact of Gallant Dm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gallant Dm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gallant Dm more than expected).

Fields of papers citing papers by Gallant Dm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gallant Dm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gallant Dm. The network helps show where Gallant Dm may publish in the future.

Co-authorship network of co-authors of Gallant Dm

This figure shows the co-authorship network connecting the top 25 collaborators of Gallant Dm. A scholar is included among the top collaborators of Gallant Dm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gallant Dm. Gallant Dm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dm, Gallant, et al.. (1976). A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients.. PubMed. 19(1). 99–104. 98 indexed citations
2.
Dm, Gallant, et al.. (1975). Assessment of antipsychotic activity of an unique agent: SU-23397.. PubMed. 1(2). 117–22. 2 indexed citations
3.
Dm, Gallant. (1975). Potential value of penfluridol and pipothiazine palmitate.. PubMed. 11(1). 11–2. 5 indexed citations
4.
Rabins, Peter V., et al.. (1974). A comparison of two methods of determining drug use among university students.. PubMed. 126(1). 1–4. 1 indexed citations
5.
Dm, Gallant, et al.. (1973). U-28,774 (ketozolam): an early evaluation of a new antianxiety agent.. PubMed. 15(3). 123–6. 7 indexed citations
6.
Dm, Gallant, et al.. (1973). Tacitin: a preliminary evaluation in chronic alcoholic patients presenting the target symptomatology of anxiety.. PubMed. 15(3). 113–5. 1 indexed citations
7.
Dm, Gallant, et al.. (1973). Loxapine: a six-month evaluation in severely ill schizophrenic patients.. PubMed. 15(4). 205–9. 5 indexed citations
8.
Dm, Gallant, et al.. (1973). Amoxapine: a double-blind evaluation of antidepressant activity.. PubMed. 15(2). 56–9. 8 indexed citations
9.
Dm, Gallant, et al.. (1972). GP-45795: a controlled evaluation in chronic schizophrenic patients.. PubMed. 14(4). 215–9. 2 indexed citations
10.
Dm, Gallant, et al.. (1972). ORF-8063: an early evaluation of a new antianxiety agent.. PubMed. 14(10). 664–6. 1 indexed citations
11.
Dm, Gallant, et al.. (1970). Group psychotherapy with married couples: a successful technique in New Orleans alcoholism clinic patients.. PubMed. 122(2). 41–4. 33 indexed citations
12.
Dm, Gallant. (1970). Psychopharmacologic research in severely chronic schizophrenic inpatients.. PubMed. 6(4). 4–24. 1 indexed citations
13.
Dm, Gallant, et al.. (1968). Extended trial of thiothixene in chronic psychotic patients.. PubMed. 29(8). 15–22. 6 indexed citations
14.
Dm, Gallant, et al.. (1968). A six-month controlled evaluation of metronidazole (Flagyl) in chronic alcoholic patients.. PubMed. 10(2). 82–7. 13 indexed citations
15.
Guerrero-Figueroa, R & Gallant Dm. (1967). Effects of pinoxepin and imipramine on the mesencephalic reticular formation and amygdaloid complex in the cat: neurophysiological and clinical correlations in human subjects.. PubMed. 9(7). 387–403. 3 indexed citations
16.
Dm, Gallant, et al.. (1966). A double-blind study of thozalinone (C1 39,808) in depressed outpatients.. PubMed. 8(12). 621–2. 2 indexed citations
17.
Dm, Gallant, et al.. (1964). COMPARISON OF HALOPERIDOL, TRIFLUPERIDOL, AND CHLORPROMAZINE IN ACUTE SCHIZOPHRENIC PATIENTS.. PubMed. 6. 562–71. 15 indexed citations
18.
Dm, Gallant, et al.. (1964). ANTI-SEROTONIN ACTIVITY AND CLINICAL TRANQUILIZATION.. PubMed. 5. 273–8. 2 indexed citations
19.
Dm, Gallant, et al.. (1964). JB-8181: ANTIDEPRESSANT ACTIVITY IN OUTPATIENTS.. PubMed. 6. 69–70. 1 indexed citations
20.
Dm, Gallant, et al.. (1964). A CONTROLLED EVALUATION OF BUTAPERAZINE IN CHRONIC SCHIZOPHRENIC PATIENTS.. PubMed. 25. 674–83. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026